Study number 779857
Dates
Apr 30 2026-Jul 10 2026
Group
Cohort 5 OR 8
Location
Daytona Beach, Florida
Age
18-65
Gender
Male OR Female
Smoker
Yes
Compensation
$12,049
Referral
$350
This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease.
Daytona Beach, FL is currently recruiting Healthy Adults, ages 18-65.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
Smoking Criteria
Body Mass Index
Screening procedures
Call Now to Schedule Your Screening Appointment!
Cohort 5:
Check-in: Apr 30
Check-out: May 1
Follow up Visits: May 3, 5, 8, 11, 15, 22, 29, Jun 12, 26, Jul 10
Phone Calls: Jun 5, 19, Jul 3
Compensation Schedule:
Day 11 (May 11): $3,794
Day 22 (May 22): $2,355
Day 43 (Jun 12): $1,570
Day 57 (Jun 26): $1,620
Day 71 (Jul 10): $2,710
OR
Cohort 8:
Check-in: May 6
Check-out: May 7
Follow up Visits: May 9, 11, 14, 17, 21, 28, Jun 4, 18, Jul 2, 16
Phone Calls: Jun 11, 25, Jul 16
Compensation Schedule:
Day 11 (May 17): $3,794
Day 22 (May 28): $2,355
Day 43 (Jun 18): $1,570
Day 57 (Jul 2): $1,620
Day 71 (Jul 16): $2,710